Literature DB >> 10413204

Seasonal variations in activity of systemic lupus erythematosus in a subarctic region.

H J Haga1, J G Brun, O P Rekvig, L Wetterberg.   

Abstract

Photosensitivity is one of the major clinical features of Systemic Lupus Erythematosus (SLE), and is considered to be implicated in the disease pathogenesis. We studied seasonal variations of SLE disease activity at latitude 70 degrees North where there is no sunlight in the winter time, in contrast to 24 h daily sunlight in the summer (midnight sun). The associations between the level of plasma melatonin in June and December with disease manifestations were also studied. Twenty-one SLE patients were examined each month for 1 y, and disease activity was assessed by laboratory parameters as well as clinical disease activity parameters SLEDAI and doctor's global assessment. Melatonin levels were quantified by a RIA-assay. There was no significant change of clinical measures or laboratory parameters of disease activity from one month to the next during the one year, except photosensitive rashes. January was the only month without SLE-flares or arthritis, in contrast to rest of the year. The levels of plasma melatonin were highest in December for seven patients and highest in June for one patient (P < 0.005). Plasma melatonin levels did not correlate with measures of clinical disease activity. At a latitude of 70 degrees North there were no major seasonal variations in SLE disease activity during the one year. There was an accumulation of photosensitivity in the summer months, but no indications of worsening of the disease in the winter months. In contrast to the rest of the year, there was no flare in January which had only 5.6 h of sunshine. The level of p-melatonin did not correlate with measures of disease activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413204     DOI: 10.1191/096120399678847858

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Seasonal variation in the activity of systemic lupus erythematosus.

Authors:  Alí Duarte-García; Hong Fang; Chi Hung To; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

Review 2.  A review of the multiple actions of melatonin on the immune system.

Authors:  Antonio Carrillo-Vico; Juan M Guerrero; Patricia J Lardone; Russel J Reiter
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

3.  Prior anti-dsDNA antibody status does not predict later disease manifestations in systemic lupus erythematosus.

Authors:  Loes van den Berg; Hans Nossent; Ole Rekvig
Journal:  Clin Rheumatol       Date:  2005-11-23       Impact factor: 2.980

4.  Increased lipid and protein oxidation and lowered anti-oxidant defenses in systemic lupus erythematosus are associated with severity of illness, autoimmunity, increased adhesion molecules, and Th1 and Th17 immune shift.

Authors:  Bruna Miglioranza Scavuzzi; Andréa Name Colado Simão; Tatiana Mayumi Veiga Iriyoda; Marcell Alysson Batisti Lozovoy; Nicole Perugini Stadtlober; Lorena Flor da Rosa Franchi Santos; Tamires Flauzino; Fabiano Aparecido de Medeiros; Marcelo Cândido de Sá; Luana Consentin; Edna Maria Vissoci Reiche; Michael Maes; Isaias Dichi
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 5.  The beneficial role of vitamin D in systemic lupus erythematosus (SLE).

Authors:  Khanh vinh quốc Luong; Lan Thi Hoàng Nguyễn
Journal:  Clin Rheumatol       Date:  2012-07-17       Impact factor: 2.980

6.  Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.

Authors:  M Pertovaara; T Hasan; A Raitala; S S Oja; U Yli-Kerttula; M Korpela; M Hurme
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

Review 7.  The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus.

Authors:  Rachel S Klein; Robert M Sayre; John C Dowdy; Victoria P Werth
Journal:  Autoimmun Rev       Date:  2008-11-06       Impact factor: 9.754

8.  Plasma melatonin levels do not differ in SLE patients.

Authors:  P Wang; H-M Li; Y-F Zou; J-H Tao; H-F Pan
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

9.  Higher genetic susceptibility to inflammation in mild disease activity of systemic lupus erythematosus.

Authors:  Li-Jen Tsai; Sheng-Hsiung Hsiao; Jaw-Ji Tsai; Ching-Yuang Lin; Lih-Min Tsai; Joung-Liang Lan
Journal:  Rheumatol Int       Date:  2009-04-28       Impact factor: 2.631

10.  Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report.

Authors:  Ralitsa Robeva; Dobromir Tanev; Georgi Kirilov; Milena Stoycheva; Analia Tomova; Philip Kumanov; Rasho Rashkov; Zlatimir Kolarov
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.